{
    "nct_id": "NCT04266431",
    "official_title": "EMPOWER Men to Reduce Weight and Inhibit Prostate Cancer Progression",
    "inclusion_criteria": "* Understand and voluntarily sign consent form\n* Able to adhere to study protocol\n* Demonstrated use of internet and email\n* Access to internet at least 4 days per week\n* Willingness to change diet, physical activity and weight\n* Willingness to be randomized to immediate start or standard of care\n* Histologically confirmed diagnosis of adenocarcinoma of the prostate with evidence of biochemical recurrence following local therapy (surgery and radiation will be allowed). Biochemical recurrence will be defined as a PSA >= 0.2 ng/mL.\n* Surgically treated men must not be eligible for or decline salvage radiation. Men who recurred within 3 years of completion of salvage radiation will be included.\n* Definitive therapy (surgery or radiation) should be at least 4 weeks from time of consent.\n* Men who received prior hormone therapy with definitive local therapy (standard with radiation) are permitted if serum testosterone level is >150 ng/dL and hormone treatment was discontinued > 1 year from time of enrollment.\n* Body mass index >= 25 kg/m2\n* Eastern Cooperative Oncology Group (ECOG) performance status < 2\n* Willingness to return for clinical visit at 6 months, 12 months, and 24 months\n* Men receiving testosterone replacement therapy will be included if they are on a stable dose with testosterone levels in the normal range.\nHealthy volunteers allowed\nMust be MALE\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Any clinical or radiographic evidence of metastatic disease by computed tomography (CT) of the chest, abdomen and pelvis and technetium-99 bone scintigraphy (bone scan)\n* MI, stroke or ASCVD procedure within 6 months\n* Serious medical condition likely to hinder accurate measurement of weight, or for which weight loss is contraindicated, or which would cause weight loss\n* Unstable angina or medical conditional that would prevent routine exercise\n* Prior or planned bariatric surgery\n* Use of prescription weight loss medication (including off label use of medications) or over-the-counter orlistat within 6 months\n* Chronic use (at least past 6 months) of medications likely to cause weight gain or prevent weight loss (e.g. corticosteroids, lithium, olanzapine, risperidone, clozapine), including androgen deprivation therapy\n* Unintentional or intentional weight loss within 6 months of enrollment (â‰¥ 5% of body weight)",
    "miscellaneous_criteria": ""
}